首页> 外文会议>International Symposium on Ganoderma Research >The Follow-up Observation Assessment of Medium and Late Phases Cancer Treated by Chinese Ganoderma lucidum Essence (CGLE)
【24h】

The Follow-up Observation Assessment of Medium and Late Phases Cancer Treated by Chinese Ganoderma lucidum Essence (CGLE)

机译:中国灵芝精华治疗癌症的中期阶段癌症的后续观察评估(Contle)

获取原文

摘要

The Follow-up Observation Assessment of Medium and Late Phases Cancer Treated by Chinese Ganoderma lucidum Essence, as to the follow-up observation results of the treatments to 547 medium and late phases cancer sufferers, analysis and comparison are made in the aspects of surviving period, life quality and death rate etc., and assessment is made on the curative effect of this medicine on the terminal cancer therapy. There is certain referential value for the research on the combination of Chinese traditional and western medicine as well as cancer exterior and interior multi-treatments. Perhaps it has some realistic referential significance to the Combining Substitutional Medicine with Integration Medicine Therapy that is newly proposed.
机译:中国灵芝精华治疗的中期阶段癌症的后续观察评估,关于治疗的后续观察结果,对547中期和晚期癌症患者,分析和比较进行了幸存的时期,生活质量和死亡率等,对该药对末端癌症治疗的疗效作出评估。中国传统和西医结合研究以及癌症外部和室内多治疗的研究存在一定的参考价值。也许它对新提出的集成药物治疗具有一些现实的参照学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号